SYRS
Syros Pharmaceuticals Inc.

2,827
Mkt Cap
$21,466.00
Volume
2,922.00
52W High
$0.2969
52W Low
$0.0001
Price
$0.0002
SYRS Fundamentals
Prev Close
$0.0008
Open
$0.0002
50D MA
$0.0005
Beta
11.78
Avg. Volume
38,964.41
Loading...
Loading...
Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609. The company was founded by Richard A. Young, Nathanael S. Gray, and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Syros Pharmaceuticals Inc.?
What is the 52-week high for Syros Pharmaceuticals Inc.?
What is the 52-week low for Syros Pharmaceuticals Inc.?
What is Syros Pharmaceuticals Inc. stock price today?
What was Syros Pharmaceuticals Inc. stock price yesterday?
What is the 50-day moving average of Syros Pharmaceuticals Inc.?

Latest SYRS News

View
No SYRS news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.